Update on HIV-1 strain and transmitted drug resistance in Canada : findings from the Canadian HIV Strain and Drug Resistance Surveillance Program, 2012-2013.: HP40-192/2017E-PDF
"HIV is a significant public health challenge. A key component in monitoring the epidemicis surveillance on HIV subtypes and drug resistance. Subtype B historically constituted over 95% of new diagnoses in Canada; however, the proportion of non-B subtypes has gradually been increasing and now represents about 20% of new diagnoses. Surveillance on HIV subtypes informs vaccine development and provides the opportunity to examine potential variation in transmission risk and treatment success by subtype. Moreover, national HIV drug resistance surveillance is important since transmission of drug-resistant HIV impacts treatment and also prevention and control activities. In 1998, the Public Health Agency of Canada (PHAC) created the Canadian HIV Strain and Drug Resistance Surveillance Program (SDR Program) to monitor HIV-1 subtypes and pre-treatment antiretroviral resistance in Canada. Six provinces collaborate with PHAC on this initiative: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Nova Scotia"--Executive summary, p. 3.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.843746&sl=0
| Department/Agency | Public Health Agency of Canada. |
|---|---|
| Title | Update on HIV-1 strain and transmitted drug resistance in Canada : findings from the Canadian HIV Strain and Drug Resistance Surveillance Program, 2012-2013. |
| Variant title | Findings from the Canadian HIV Strain and Drug Resistance Surveillance Program, 2012-2013 |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | "Publication date: November 2017." "Protecting and empowering Canadians to improve their health"--Cover. Issued also in French under title: Mise à jour sur les souches du VIH-1 et la pharmacorésistance transmise au Canada : résultats du Programme canadien de surveillance des souches et de la résistance aux médicaments ayant trait au VIH, 2012-2013. Includes bibliographical references. |
| Publishing information | Ottawa : Public Health Agency of Canada, 2017. |
| Description | vi, 39 p. : graphs |
| ISBN | 978-0-660-09724-4 |
| Catalogue number |
|
| Departmental catalogue number | Pub.: 170240 |
| Subject terms | AIDS (disease) Drug use Immunization |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: